Vitamin D and prostate cancer: The role of membrane initiated signaling pathways in prostate cancer progression
Authors:
- Sandra KarlssonSKSandra Karlsson
- Josefin OlaussonJOJosefin Olausson
- Dan LundhDLDan Lundh
- Peter SögårdPSPeter Sögård
- Abul MandalAMAbul Mandal
- Kjell-Ove HolmströmKHKjell-Ove Holmström
- Anette StahelASAnette Stahel
- Jenny BengtssonJBJenny Bengtsson
- Dennis LarssonDLDennis Larsson
- 1 July 2010
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 121 (1-2) , 413-416
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Membrane Receptors for Vitamin D MetabolitesCritical Reviews™ in Eukaryotic Gene Expression, 2007
- The Role of Vitamin D in Cancer PreventionAmerican Journal of Public Health, 2006
- Identification and characterization of 1,25D-membrane-associated rapid response, steroid (1,25D-MARRS)-binding protein in rat IEC-6 cellsSteroids, 2005
- Steadying the boat: integrating mechanisms of membrane and nuclear‐steroid‐receptor signallingEMBO Reports, 2005
- The Vitamin D Receptor Is Present in Caveolae-Enriched Plasma Membranes and Binds 1α,25(OH)2-Vitamin D3in Vivo and in VitroMolecular Endocrinology, 2004
- The role of Vitamin D3 metabolism in prostate cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Ribozyme knockdown functionally links a 1,25(OH) 2 D 3 membrane binding protein (1,25D 3 -MARRS) and phosphate uptake in intestinal cellsProceedings of the National Academy of Sciences, 2004
- Rapid modulation of osteoblast ion channel responses by 1α,25(OH) 2 -vitamin D 3 requires the presence of a functional vitamin D nuclear receptorProceedings of the National Academy of Sciences, 2004
- Prostate CancerNew England Journal of Medicine, 2003
- The development of androgen-independent prostate cancerNature Reviews Cancer, 2001